Remanded
EB-2 NIW
EB-2 NIW Remanded — Pharmaceutical Science (2023): the Director's Notice of Intent to Revoke (NOIR) was
Filing your own EB-2 NIW? See how your CV maps to the criteria this decision turned on — free strategy preview.
Decision Summary
The appeal was remanded because the Director's Notice of Intent to Revoke (NOIR) was procedurally deficient. The AAO found that the NOIR misapplied the evidence to the wrong prongs of the Dhanasar framework and did not sufficiently detail the elements of willful misrepresentation, thus failing to provide the petitioner with a proper opportunity to rebut the derogatory evidence.
See how a decision like this gets cited in an EB-2 NIW petition →Criteria Discussed
Substantial Merit And National Importance Well-Positioned To Advance Proposed Endeavor Benefit To The U.S. To Waive Job Offer Willful Misrepresentation Procedural Requirements For Revocation (Noir)
📄 Original decision (USCIS PDF)
Sign up free to download the original PDF
Downloaded the case? Use it in your next draft →Filing your own EB-2 NIW? See where you stand.
Upload your CV and see how your profile maps to USCIS criteria — free strategy preview, no credit card.
Map Your CV to These Criteria →No credit card required.